https://nextgen-health.net/articles/ecopipam-tourette-syndrome-childrenNextGenHealthen2026-11-04T08:00:00+00:00A new mechanism for Tourette syndrome nears an FDA decision https://nextgen-health.net/articles/deramiocel-fda-decision-duchenne-novemberNextGenHealthen2026-11-04T08:00:00+00:00Capricor's Duchenne cell therapy nears an FDA decision on a narrower claim https://nextgen-health.net/articles/amifampridine-generic-lupin-2035-lemsNextGenHealthen2026-11-04T08:00:00+00:00Lupin wins approval for generic amifampridine, but patients may wait until 2035 https://nextgen-health.net/articles/berotralstat-pellets-age-12-hereditary-angioedemaNextGenHealthen2026-11-02T08:00:00+00:00A pellet built for young children reaches adults with hereditary angioedema https://nextgen-health.net/articles/mirikizumab-shine-2-paediatric-ulcerative-colitisNextGenHealthen2026-11-02T08:00:00+00:00Mirikizumab posts one-year phase 3 results in paediatric ulcerative colitis https://nextgen-health.net/articles/mhra-october-roundup-paediatric-medicinesNextGenHealthen2026-11-02T08:00:00+00:00The MHRA's October round-up shows where children's medicines are most exposed